UKRI-2310 Hub Function for the UK Rare Disease Research Platform

Text to be corrected in the original notice: Place of text to be modified: Time limit for receipt of tenders or requests to participate Instead of: 20 February 2023 Time: 14:00 Read New: 27 February 2023 Time: 14:00 Other additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement. The UK Rare Disease Research Platform (UK-RDRP) is being established by MRC and NIHR to connect and enhance the UK's strengths in rare disease research. Rare diseases are defined as diseases with a prevalence of less than one in 2000 individuals, and include disease of genetic and non-genetic origins. The aim of the Platform is to underpin greater collaboration between academic, clinical and industry research with essential patients, research charities and other stakeholders to accelerate the understanding, diagnosis and therapy of rare diseases. The Platform will support networking and activities that enable research and will comprise a number of challenge-led thematic nodes (each led by UK research organisations, e.g. universities), with a single, integrated platform Hub.